Omega Pharma NV, a Belgian healthcare products distributor, is considering selling itself nearly three years after it was taken private by its founder, Bloomberg reported on Monday, citing sources. A sale of the Nazareth, Belgium-based company could earn its owners more than $4 billion, the news agency quoted a person familiar with the matter as saying. (bloom.bg/1qccu2V)Omega Pharma could not immediately be reached for a comment.The company, which sells prescription-free medicines, healthcare products and over-the-counter (OTC) items such as wart treatments and sun tan lotions, was working with investment bank Morgan Stanley on the sale, and the process could start as early as this month, sources told Bloomberg.Founder and CEO Marc Coucke succeeded in taking the company private in 2011 with his $1.1 billion takeover offer for the maker of painkiller Solpadeine. (reut.rs/1r3x9Yx)
Morgan Stanley is a global financial services company that, through its subsidiaries and affiliates, provides its products and services to a range of clients and customers, including corporations, governments, financial institutions and individuals. Shares of MS fell by 1.09% or $-0.355/share to $32.26. In the past year, the shares have traded as low as $24.16 and as high as $33.52. On average, 10621600 shares of MS exchange hands on a given day and today's volume is recorded at 3687510.
Source
